Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-03-17
1990-11-27
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 8, 530325, 530326, 530324, 530395, 530397, 530850, 530854, C07K 708, C07K 1514, A61K 3738, A61K 3702
Patent
active
049735780
ABSTRACT:
Synthetic peptides corresponding to .alpha.-subunit of human glycoprotein hormone amino acid regions .alpha.31-45, .alpha.21-35, .alpha.26-46 and .alpha.81-92; were found to inhibit binding of 125.sub.I-bTSH to human thyroid. Peptides corresponding to regions .alpha.26-46 and .alpha.31-45 were also found to potently inhibit the stimulation of adenylate cyclase activity by bTSH in a TSH bioassay using FRTL-5 cells and block the action of thyroid stimulating immunoglobulin.
REFERENCES:
patent: 3941763 (1976-03-01), Sarantakis
patent: 4609622 (1986-09-01), Kohn
P. Licht et al., Recent Prog. Horm. Res., 33:169-248 (1977).
J. L. Vaitukaitis et al., Recent Prog. Horm. Res., 32:289-331 (1976).
D. N. Ward et al., Recent Prog. Horm. Res., 29:533-561 (1973).
H. Papkoff et al., Recent Prog. Horm. Res., 29:563-590 (1973).
R. E. Canfield et al., Recent Prog. Horm. Res., 27:121-164 (1971).
J. G. Pierce et al., Recent Prog. Horm. Res., 27:165-212 (1971).
R. J. Ryan et al., Recent Prog. Horm. Res., 26:105-137 (1970).
Ascoli and Segaloff, J. Biol. Chem., 261:3807-3815 (1986).
Grasso and Crisp, Endocrinology, 116:319-327 (1985).
Ji and Ji, Proc. Natl. Acad. Sci. USA, 78:5465-5469 (1981).
Moudgal and Li, Proc. Natl. Acad. Sci. USA, 79:2500-2503 (1982).
Pierce and Parsons, Ann. Rev. Biochem., 50:465-495 (1981).
Armstrong et al., Biochemical Actions of Hormones, 13:91-128 (1986).
Davies and Platzer, Clinical Endocrinology, 19:427-435 (1983).
Fahraeus-van Ree and Farid, Clinical Research, 31, No. 3 (1983).
Smith and Buckland, Receptors, Antibodies and Disease: Ciba Foundation Symposium 90, pp. 114-132 (Pitman, London, Pub., 1982).
Volpe, "Pathogenesis of Autoimmune Thyroid Disease", The Thyroid: A Fundamental and Clinical Text, pp. 747-767 (5th ed., 1986).
Hagenmaier and Frank, Hoppe-Seyler's Z. Physiol. Chem., 353:1973-1976 (1972).
Kaiser et al., Anal. Biochem., 34:595-598 (1970).
Stewart and Young, Laboratory Techniques in Solid Phase Peptide Synthesis, pp. 53-124 (Pierce Chem. Co., Pub. 2d ed. 1984).
Ambesi-Impiombato et al., Proc. Natl. Acad. Sci. USA, 77:3455-3459 (1980).
Lee and Ryan, Biochemistry, 12:4609-4615 (1973).
Takahashi et al., J. Clinical Endocrinol. Metab., 47:870-876 (1978).
Bidey et al., J. Endocr., 101:269-276 (1984).
Kasagi et al., Acta Endocrinol., 115:30-36 (1987).
Tramontano and Ingbar, Endocrinology, 118:1945-1951 (1986).
Steiner et al., J. Biol. Chem., 247:1106-1113 (1972).
Wray and Glinos, Am. J. Physiol., 234(5):C131-C138 (1978).
Klee and Hay, J. Clin. Endocrinol. Metab., 64:461-471 (1987).
Furmaniak et al., Acta Endocrinol., Suppl. 281:157-165 (1987).
Furmaniak et al., Program of the 62nd Meeting of the American Thyroid Association, p. T-62 (1987).
Bishop and Ryan, Biochemistry, 12:3076-3084 (1973).
Canfield et al., Studies of Human Chorionic Gonadotropin, pp. 121-164 (1971).
Charlesworth, McCormick, Madden, and Ryan, J. Biol. Chem., 262:13409-13416 (Oct. 5, 1987).
Keutmann et al., Hoppe-Seyler's Z. Physiol. Chem., 355:935-938 (1974).
Licht et al., Evolution of Gonadotropin Structure and Function, pp. 169-248 (1977).
Papkoff et al., Studies on the Structure and Function of Interstitial Cell-Stimulating Hormone, pp. 563-590 (1972).
Pierce et al., Studies on the Structure of Thyrotropin: Its Relationship to Luteinizing Hormone, pp. 165-212 (1971).
Ryan et al., Some Physical and Hydrodynamic Properties of Human FSH and LH, pp. 105-137 (1969).
Ryan et al., Recent Prog. Horm. Res., 43:383-429 (Jun., 1987).
Smith
This invention was made with Government support under grant number HD 9140 by the National Institute of Health and funds from the Mayo Foundation. The Government has certain rights in the invention.
Charlesworth M. Cristine
McCormick Daniel J.
Morris John C.
Ryan Robert J.
Mayo Foundation for Medical Education and Research
Moezie F. T.
LandOfFree
Synthetic peptides derived from the alpha-subunit of human lycop does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic peptides derived from the alpha-subunit of human lycop, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic peptides derived from the alpha-subunit of human lycop will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1031958